CN102892776B - 新型肽及其用途 - Google Patents

新型肽及其用途 Download PDF

Info

Publication number
CN102892776B
CN102892776B CN201180004884.2A CN201180004884A CN102892776B CN 102892776 B CN102892776 B CN 102892776B CN 201180004884 A CN201180004884 A CN 201180004884A CN 102892776 B CN102892776 B CN 102892776B
Authority
CN
China
Prior art keywords
peptide
cartilage
leu
pharmaceutically acceptable
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201180004884.2A
Other languages
English (en)
Chinese (zh)
Other versions
CN102892776A (zh
Inventor
金海镇
李济旭
权永准
文银贞
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
First Biological Sciences Ltd
Original Assignee
ENSOLTEK CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ENSOLTEK CO Ltd filed Critical ENSOLTEK CO Ltd
Publication of CN102892776A publication Critical patent/CN102892776A/zh
Application granted granted Critical
Publication of CN102892776B publication Critical patent/CN102892776B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1841—Transforming growth factor [TGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
CN201180004884.2A 2010-06-30 2011-06-22 新型肽及其用途 Active CN102892776B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR10-2010-0062467 2010-06-30
KR1020100062467A KR101029705B1 (ko) 2010-06-30 2010-06-30 신규 펩타이드 및 그 용도
PCT/KR2011/004541 WO2012002668A2 (en) 2010-06-30 2011-06-22 Novel peptide and use thereof

Publications (2)

Publication Number Publication Date
CN102892776A CN102892776A (zh) 2013-01-23
CN102892776B true CN102892776B (zh) 2014-07-16

Family

ID=44050220

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201180004884.2A Active CN102892776B (zh) 2010-06-30 2011-06-22 新型肽及其用途

Country Status (14)

Country Link
US (1) US8772241B2 (enExample)
EP (1) EP2588491B1 (enExample)
JP (1) JP5607176B2 (enExample)
KR (1) KR101029705B1 (enExample)
CN (1) CN102892776B (enExample)
AU (1) AU2011272137B2 (enExample)
BR (1) BR112012031587B1 (enExample)
CA (1) CA2801010C (enExample)
ES (1) ES2606778T3 (enExample)
MX (1) MX2012015000A (enExample)
PL (1) PL2588491T3 (enExample)
RU (1) RU2525913C1 (enExample)
SG (1) SG186120A1 (enExample)
WO (1) WO2012002668A2 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104886564B (zh) * 2015-05-12 2017-05-17 浙江海洋学院 一种路氏双髻鲨软骨血管生成抑制因子的用途
KR101644982B1 (ko) * 2015-07-23 2016-08-02 주식회사 엔솔바이오사이언스 신규 펩타이드 및 그 용도
US10913771B2 (en) 2016-03-09 2021-02-09 Kine Sciences Co., Ltd. Peptide for preventing or treating inflammatory diseases and use thereof
US10206969B2 (en) 2016-03-09 2019-02-19 Bio Pep Co., Ltd. Peptide for preventing or treating inflammatory diseases and use thereof
WO2017155234A1 (ko) * 2016-03-09 2017-09-14 주식회사 바이오펩 염증성 질환의 예방 또는 치료용 펩타이드 및 이의 용도
KR101897122B1 (ko) * 2016-03-09 2018-09-10 주식회사 바이오펩 염증성 질환의 예방 또는 치료용 펩타이드 및 이의 용도
US10913772B2 (en) 2016-03-09 2021-02-09 Kine Sciences Co., Ltd. Peptide for preventing or treating inflammatory diseases and use thereof
JP6858325B2 (ja) * 2016-07-20 2021-04-14 エンソル バイオサイエンス インコーポレイテッド 新規ペプチド及びその用途
CN107670021B (zh) * 2016-08-02 2020-09-18 富比积生物科技股份有限公司 五胜肽kttks在治疗退化性关节炎中的用途
WO2019054809A2 (ko) * 2017-09-15 2019-03-21 주식회사 바이오펩 자가면역질환 및 골질환 치료제로서의 펩타이드의 용도
CN111093687B (zh) 2017-09-15 2024-07-09 凯恩塞恩斯株式会社 作为自身免疫疾病及骨病治疗剂的肽的用途
KR101995768B1 (ko) * 2019-03-13 2019-07-03 (주)엔솔바이오사이언스 신규 펩타이드 및 그 용도
KR20230167231A (ko) 2022-05-31 2023-12-08 주식회사 엔솔바이오사이언스 염형태 변형 펩타이드의 제조방법 및 그를 이용하여 제조된 펩타이드
KR20230167253A (ko) 2022-05-31 2023-12-08 주식회사 엔솔바이오사이언스 펩타이드 함유 액상제제 및 그 제조방법
KR20240086946A (ko) * 2022-12-09 2024-06-19 (주)케어젠 연골 재생용 펩타이드 및 이의 용도
KR102877150B1 (ko) * 2022-12-09 2025-10-28 (주)케어젠 연골 재생용 펩타이드 및 이의 용도
WO2025089468A1 (ko) * 2023-10-27 2025-05-01 주식회사 엔솔바이오사이언스 펩타이드 함유 액상제제 및 그 제조방법

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000002916A2 (en) * 1998-07-10 2000-01-20 The Regents Of The University Of California PEPTIDE COMPOSITIONS MIMICKING TGF-β ACTIVITY
EP1400252A1 (en) * 1999-02-01 2004-03-24 Genetics Institute, LLC Methods and compositions for healing and repair of articular cartilage
US20090074876A1 (en) * 2007-01-22 2009-03-19 Acologix, Inc. Peptide composition and a method of promoting cartilage formation
CN101611051A (zh) * 2005-02-16 2009-12-23 加州大学董事会 治疗或预防骨疾病的药物组合物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5955343A (en) 1992-12-28 1999-09-21 Massachusetts Institute Of Technology Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor
US7687462B2 (en) * 1999-10-05 2010-03-30 The Regents Of The University Of California Composition for promoting cartilage formation or repair comprising a nell gene product and method of treating cartilage-related conditions using such composition
US6716811B1 (en) * 2000-07-20 2004-04-06 Affymax, Inc. Compounds having affinity for the granulocyte-colony stimulating factor receptor (G-CSFR) and associated uses
WO2002062961A2 (en) 2001-02-06 2002-08-15 Massachusetts Institute Of Technology Peptide scaffold encapsulation of tissue cells and uses thereof
ES2304069B1 (es) * 2003-08-22 2009-08-12 Proyecto De Biomedicina Cima, S.L. Peptidos con capacidad de unirse al factor transformante de crecimiento beta 1 (tgf-b1).
US8039258B2 (en) 2004-09-28 2011-10-18 Ethicon, Inc. Tissue-engineering scaffolds containing self-assembled-peptide hydrogels
CA2618163A1 (en) * 2008-02-07 2009-08-07 K. W. Michael Siu Head and neck cancer biomarkers

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000002916A2 (en) * 1998-07-10 2000-01-20 The Regents Of The University Of California PEPTIDE COMPOSITIONS MIMICKING TGF-β ACTIVITY
EP1400252A1 (en) * 1999-02-01 2004-03-24 Genetics Institute, LLC Methods and compositions for healing and repair of articular cartilage
CN101611051A (zh) * 2005-02-16 2009-12-23 加州大学董事会 治疗或预防骨疾病的药物组合物
US20090074876A1 (en) * 2007-01-22 2009-03-19 Acologix, Inc. Peptide composition and a method of promoting cartilage formation

Also Published As

Publication number Publication date
EP2588491A2 (en) 2013-05-08
BR112012031587A2 (pt) 2017-12-05
WO2012002668A3 (en) 2012-04-26
RU2525913C1 (ru) 2014-08-20
BR112012031587B1 (pt) 2021-07-13
EP2588491A4 (en) 2013-12-04
SG186120A1 (en) 2013-01-30
PL2588491T3 (pl) 2017-03-31
WO2012002668A2 (en) 2012-01-05
CN102892776A (zh) 2013-01-23
RU2013101051A (ru) 2014-08-10
MX2012015000A (es) 2013-02-07
CA2801010A1 (en) 2012-01-05
US20130109626A1 (en) 2013-05-02
EP2588491B1 (en) 2016-09-14
KR101029705B1 (ko) 2011-04-18
AU2011272137B2 (en) 2016-09-29
JP2013513657A (ja) 2013-04-22
ES2606778T3 (es) 2017-03-27
CA2801010C (en) 2015-10-13
JP5607176B2 (ja) 2014-10-15
US8772241B2 (en) 2014-07-08
AU2011272137A1 (en) 2013-02-14

Similar Documents

Publication Publication Date Title
CN102892776B (zh) 新型肽及其用途
EP2117578B1 (en) A peptide composition and a method of promoting cartilage formation
ES2844048T3 (es) Péptido para reparar cartílago y tratar la osteoartritis
CN111320682B (zh) 多肽在制备促进软骨修复和/或治疗骨关节炎药物中的用途
KR102666922B1 (ko) 미토콘드리아에 비오틴의 전달을 위한 방법 및 조성물
KR101736280B1 (ko) 관절염 예방 또는 치료용 약학적 조성물
CN111358937A (zh) Fgf-2衍生多肽在制备促进软骨修复和/或治疗骨关节炎药物中的用途
CN110903381B (zh) 一种促进软骨再生的肽kai 11及其应用
EP4631957A1 (en) Peptide for cartilage regeneration, and uses thereof
JP2025540330A (ja) 軟骨再生用ペプチド及びその用途
JP2025540312A (ja) 軟骨再生用ペプチド及びその用途
JP2025540314A (ja) 軟骨再生用ペプチド及びその用途
CN110950927A (zh) 一种促进软骨再生的肽ggs11及其应用

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C56 Change in the name or address of the patentee
CP01 Change in the name or title of a patent holder

Address after: South Korea field wide area

Patentee after: First Biological Sciences Ltd

Address before: South Korea field wide area

Patentee before: Ensoltek Co., Ltd.